Astrana Health [ASTH] vs HCA Healthcare [HCA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Astrana Health Inc. wins in 7 metrics, HCA Healthcare Inc. wins in 13 metrics, with 0 ties. HCA Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Astrana Health Inc. HCA Healthcare Inc. Better
P/E Ratio (TTM) 73.30 16.86 HCA Healthcare Inc.
Price-to-Book Ratio 2.12 -38.44 Astrana Health Inc.
Debt-to-Equity Ratio 193.10 -17.57 Astrana Health Inc.
PEG Ratio -0.41 0.37 HCA Healthcare Inc.
EV/EBITDA 14.57 10.08 HCA Healthcare Inc.
Profit Margin (TTM) 0.71% 8.97% HCA Healthcare Inc.
Operating Margin (TTM) 1.85% 16.29% HCA Healthcare Inc.
EBITDA Margin (TTM) 1.85% 16.29% HCA Healthcare Inc.
Return on Equity 4.49% -244.82% Astrana Health Inc.
Return on Assets (TTM) 3.43% 12.44% HCA Healthcare Inc.
Free Cash Flow (TTM) $104.49M $7.69B HCA Healthcare Inc.
Dividend Yield N/A 0.59% N/A
1-Year Return 51.75% -0.75% Astrana Health Inc.
Price-to-Sales Ratio (TTM) 0.59 1.39 Astrana Health Inc.
Enterprise Value $2.10B $156.18B HCA Healthcare Inc.
EV/Revenue Ratio 0.66 2.07 Astrana Health Inc.
Gross Profit Margin (TTM) 10.00% 41.90% HCA Healthcare Inc.
Revenue per Share (TTM) $65 $320 HCA Healthcare Inc.
Earnings per Share (Diluted) $0.46 $27.94 HCA Healthcare Inc.
Beta (Stock Volatility) 0.77 1.37 Astrana Health Inc.
Short % of Float 8.35% 2.45% HCA Healthcare Inc.

Astrana Health Inc. vs HCA Healthcare Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astrana Health Inc.-0.65%-4.23%5.52%40.24%61.74%46.35%
HCA Healthcare Inc.-1.10%-6.38%-14.00%-31.06%-26.57%-21.90%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astrana Health Inc.51.75%11.50%1.87%585.25%637.65%637.65%
HCA Healthcare Inc.-0.75%38.02%77.08%384.44%1,008.79%1,116.39%

Performance & Financial Health Analysis: Astrana Health Inc. vs HCA Healthcare Inc.

MetricASTHHCA
Market Information
Market Cap i$1.88B$106.00B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i497,178795,641
90 Day Avg. Volume i435,283974,074
Last Close$36.67$363.30
52 Week Range$18.08 - $39.93$330.00 - $556.52
% from 52W High-8.16%-34.72%
All-Time High$133.23 (Nov 15, 2021)$556.52 (Mar 12, 2026)
% from All-Time High-72.48%-34.72%
Growth Metrics
Quarterly Revenue Growth0.43%0.07%
Quarterly Earnings Growth0.43%0.31%
Financial Health
Profit Margin (TTM) i0.01%0.09%
Operating Margin (TTM) i0.02%0.16%
Return on Equity (TTM) i0.04%-2.45%
Debt to Equity (MRQ) i193.10-17.57
Cash & Liquidity
Book Value per Share (MRQ)$15.94$-26.83
Cash per Share (MRQ)$8.68$5.11
Operating Cash Flow (TTM) i$114.60M$12.64B
Levered Free Cash Flow (TTM) i$227.95M$5.82B
Dividends
Last 12-Month Dividend Yield iN/A0.59%
Last 12-Month Dividend iN/A$2.94

Valuation & Enterprise Metrics Analysis: Astrana Health Inc. vs HCA Healthcare Inc.

MetricASTH (Apr 26, 2026)HCA (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i73.3016.86
Forward P/E i10.5014.13
PEG Ratio i-0.410.37
Price to Sales (TTM) i0.591.39
Price to Book (MRQ) i2.12-38.44
Market Capitalization
Market Capitalization i$1.88B$106.00B
Enterprise Value i$2.10B$156.18B
Enterprise Value Metrics
Enterprise to Revenue i0.662.07
Enterprise to EBITDA i14.5710.08
Risk & Other Metrics
Beta i0.771.37
Book Value per Share (MRQ) i$15.94$-26.83

Financial Statements Comparison: Astrana Health Inc. vs HCA Healthcare Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASTH (2025)HCA (2025)
Revenue/Sales i3.18B75.60B
Cost of Goods Sold i2.84B44.23B
COGS % of Revenue i89.3%58.5%
Gross Profit i341.53M31.37B
Gross Margin i10.7%41.5%
Research & Development iN/AN/A
Operating Income (EBIT) i78.53M11.97B
Operating Margin i2.5%15.8%
EBITDA i135.35M15.57B
EBITDA Margin i4.3%20.6%
Pre-Tax Income i39.61M9.83B
Pre-Tax Income % of Revenue i1.2%13.0%
Income Tax i15.53M2.05B
Income Tax % of Revenue i0.5%2.7%
Net Income (Profit) i24.08M7.78B
Profit Margin i0.8%10.3%

Balance Sheet & Liquidity Metrics

MetricASTH (2025)HCA (2025)
Cash & Equivalents i429.47M1.04B
Total Current Assets i863.31M15.78B
Total Current Assets % of Revenue i27.1%20.9%
Total Current Liabilities i615.27M16.35B
Total Current Liabilities % of Revenue i19.3%21.6%
Long-Term Debt i1.02B43.46B
Long-Term Debt % of Revenue i32.1%57.5%
Total Shareholders Equity i558.33M-2.77B
Retained Earnings i308.38M-5.72B
Retained Earnings % of Revenue i9.7%-7.6%
Property, Plant & Equipment i35.74M39.12B

Cash Flow Statement Comparison

MetricASTH (2025)HCA (2025)
Operating Cash Flow i109.88M12.01B
Operating Cash Flow % of Revenue i3.5%15.9%
Capital Expenditures i-10.11M-4.94B
Free Cash Flow i104.49M7.69B
FCF Margin i3.3%10.2%
Debt Repayment i-495.29M-7.39B
Common Stock Repurchase i-15.43M-10.07B

Short Interest & Institutional Ownership Analysis

MetricASTHHCA
Shares Short i2.68M3.63M
Short Ratio i6.863.37
Short % of Float i8.35%2.45%
Shares Outstanding i48.89M224.61M
Float Shares i44.36M151.19M
% Held by Insiders i20.32%16.16%
% Held by Institutions i52.52%78.70%
% Held by Public i27.16%5.14%

Dividend Analysis & Yield Comparison: Astrana Health Inc. vs HCA Healthcare Inc.

MetricASTHHCA
Last 12-Month Dividend iN/A$2.94
Last 12-Month Dividend Yield iN/A0.59%
3-Year Avg Annual Dividend iN/A$2.70
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$8.10
Ex-Dividend DateN/AMar 17, 2026